ofloxacin has been researched along with Rhinoscleroma in 2 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Rhinoscleroma: A granulomatous disease caused by KLEBSIELLA RHINOSCLEROMATIS infection. Despite its name, this disease is not limited to the nose and NASOPHARYNX but may affect any part of the RESPIRATORY TRACT, sometimes with extension to the lip and the skin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tracheal rhinoscleroma is an infectious granulomatosis of the tracheobronchial tract caused by a Gram-negative bacillus." | 1.43 | Tracheal rhinoscleroma. ( Bartolomeo, M; Bigi, A; Costes, V; Makeieff, M, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bigi, A | 1 |
| Bartolomeo, M | 1 |
| Costes, V | 1 |
| Makeieff, M | 1 |
| Kumari, JO | 1 |
1 review available for ofloxacin and Rhinoscleroma
| Article | Year |
|---|---|
Coexistence of rhinoscleroma with Rosai-Dorfman disease: is rhinoscleroma a cause of this disease?
Topics: Adult; Anti-Bacterial Agents; Biopsy; Emperipolesis; Female; Histiocytosis, Sinus; Humans; Klebsiell | 2012 |
1 other study available for ofloxacin and Rhinoscleroma
| Article | Year |
|---|---|
Tracheal rhinoscleroma.
Topics: Anti-Bacterial Agents; Dyspnea; Female; Humans; Laser Therapy; Middle Aged; Ofloxacin; Rhinoscleroma | 2016 |